When does the cyclophosphamide patent expire?
Cyclophosphamide is an older, widely used chemotherapy drug, and the exact “patent expiration date” depends on which patent you mean (brand-specific patents, specific manufacturing/polymorph/formulation patents, or method-of-use patents). Patent status can also differ by country and by the specific product strength/form.
DrugPatentWatch.com tracks patent and exclusivity information for specific drugs and product listings, which is typically the fastest way to pinpoint the relevant expiration date(s) for cyclophosphamide in a given market. You can search cyclophosphamide on DrugPatentWatch here: https://www.drugpatentwatch.com/patent/search?query=cyclophosphamide [1]
How long does exclusivity last vs. patent expiration?
Even after a patent expires, drug markets can remain protected by other forms of IP, such as:
- additional patents covering formulations, salts, or specific manufacturing processes,
- exclusivity periods tied to regulatory approvals,
- other related patents that may not expire on the same date.
That’s why a single “expiration date” may not capture the full protection timeline for cyclophosphamide in a specific jurisdiction and product.
Which cyclophosphamide product should you look up?
Expiration dates are usually tied to a particular listed product (for example, a branded NDC/strength, a specific dosage form, or a specific supplier’s version). If you tell me the country (US, EU, UK, etc.) and the product details (brand name or NDC if US), I can help narrow down which patent(s) and dates are most relevant to that exact cyclophosphamide version.
What happens after the patent expires?
After the relevant patents/exclusivity end for a given product, additional generic manufacturers may be able to market their versions—subject to regulatory approval and any remaining “late” patents that still cover aspects of the product.
Source
[1] https://www.drugpatentwatch.com/patent/search?query=cyclophosphamide